Search
for
Sort by
Research 661–690 of 1000+
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Alopecia Areata: An Updated Review for 2023
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Role of the Notch Ligand Delta1 in Embryonic and Adult Mouse Epidermis
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Two-Dimensional Biodegradable Black Phosphorus Nanosheets Promote Large Full-Thickness Wound Healing through In Situ Regeneration Therapy
- Alopecia Areata: Current Treatments and New Directions
- Lef1 Contributes to the Differentiation of Bulge Stem Cells by Nuclear Translocation and Cross-Talk with the Notch Signaling Pathway
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Hair-Growth Potential of Ginseng and Its Major Metabolites: A Review on Its Molecular Mechanisms
- Resident Memory T Cells in Autoimmune Skin Diseases
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial
- Treatment of pediatric alopecia areata: A systematic review
- Novel TMEM173 Mutation and the Role of Disease Modifying Alleles
- ERUCA SATIVA LINN.: PHARMACOGNOSTICAL AND PHARMACOLOGICAL PROPERTIES AND PHARMACEUTICAL PREPARATIONS
- New and Emerging Therapies for Alopecia Areata
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Pathomechanisms of immune-mediated alopecia
- Review of treatment for alopecia totalis and alopecia universalis